BridgeBio Oncology Therapeutics, Inc.

Paradigm Biocapital Advisors LP BBOT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

2,261,749

Value ($000)

28,317

Weight

0.8%

2025 Q3 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	28,317	0.8%	2,261,749	12/31/2025
2025 Q3	11/14/2025	21,610	0.6%	1,866,141	9/30/2025